Information submitted will be transmitted to a law firm. This communication is intended to be an attorney-client communication for purposes of evaluating your claim and will be kept confidential by the law firm. The communication does not create an attorney-client relationship and no relationship is formed until a fee agreement is signed by you and the law firm 

FREE CLAIM REVIEW

You may have a Xeljanz Claim 
Fill out the form to speak with our team. Time is Limited.

Xeljanz Claim Help

Let Us File Your Claim

Our law firm represents victims across the country; we do not represent large corporations. Victims who are injured as a result of the negligence of others are entitled to not only our concern, care, and guidance but the skill, experience, and intelligence of the best personal injury law firm. We strive for the best possible outcome for our clients and their families. We don’t get paid unless you recover damages in your case. If you don’t get paid, we don’t get paid. It’s as simple as that.

Please fill out the form above to determine your eligibility for a Xeljanz Injury lawsuit settlement or to start the process of applying.

SINCE YOUR ARTHRITIS OR COLITIS TREATMENT STARTED, HAVE YOU DEVELOPED HEART PROBLEMS, OR BEEN DIAGNOSED WITH CANCER?

Consult your doctor before discontinuing any medications. This page is not meant to be taken as medical advice.

By clicking above, I agree to receive telephone calls and text messages at the telephone number provided above/below (including any mobile number provided) by our law firm. I understand that consent is not a condition to receive the services and that I may revoke my consent at any time. I also have read and agree to your Privacy Policy.

In early February of 2021, the FDA officially acknowledged the dangers of the prescription drug Xeljanz. If you or a loved one took the drug Xeljanz or Xeljanz XR for rheumatoid arthritis, psoriatic arthritis or ulcerative colitis you could be at risk. The FDA issued a Drug Safety Communication alerting the public that the initial safety trial results linked Xeljanz to an increased risk of serious cardiovascular events and increase risk of cancer.

Injuries linked with Xeljanz after use include:

  • Cancer (Breast, Colon, Lung, NHL, Prostate)

  • Acute coronary syndrome

  • Atrial fibrillation

  • Cardiac arrest

  • Heart failure

  • Ischemic stroke

  • Arterial thrombosis

  • Blood clot

  • Deep vein thrombosis

  • Pulmonary embolism

Xeljanz Claim Help
Cardiac & Cancer Related

Xeljanz Claim Help
Cardiac & Cancer Related